Cargando…

A network pharmacology and molecular docking investigation on the mechanisms of Shanyaotianhua decoction (STT) as a therapy for psoriasis

Psoriasis is an immune-mediated inflammatory skin disease with a complex etiology involving environmental and genetic factors. Psoriasis patients often require long-term treatment. Shanyaotianua decoction (STT), a typical traditional Chinese medicine prescription, positively affects psoriasis, altho...

Descripción completa

Detalles Bibliográficos
Autores principales: Yue, Chen, Feng, Jiahao, Gao, Aili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470816/
https://www.ncbi.nlm.nih.gov/pubmed/37653756
http://dx.doi.org/10.1097/MD.0000000000034859
_version_ 1785099766446686208
author Yue, Chen
Feng, Jiahao
Gao, Aili
author_facet Yue, Chen
Feng, Jiahao
Gao, Aili
author_sort Yue, Chen
collection PubMed
description Psoriasis is an immune-mediated inflammatory skin disease with a complex etiology involving environmental and genetic factors. Psoriasis patients often require long-term treatment. Shanyaotianua decoction (STT), a typical traditional Chinese medicine prescription, positively affects psoriasis, although its molecular targets remain unknown. To elucidate its molecular mechanisms, a combination of network pharmacology, bioinformatics analysis, and drug similarity comparisons were employed. Participants were separated into 3 groups: non-lesional (NL), lesions after medication (LM), and psoriasis lesion groups (LS). Based on the Gene Ontology/kyoto encyclopedia of genes and genomes enrichment analyses, the key targets were mainly enriched for biological processes (immuno-inflammatory responses, leukocyte differentiation, lipid metabolic disorders, and viral infection) with the relevant pathways (Janus kinase/signal transducers and activators of transcription and adipocytokine signaling and T-helper 17 cell differentiation), thus identifying the possible action mechanism of STT against psoriasis. Target prediction for 18 STT compounds that matched the screening criteria was performed. Then, the STT compounds were intersected with the differentially expressed genes of the psoriatic process, and 5 proteins were potential targets for STT. Based on the open-source toolkit RDKit and DrugBank database, and through molecular docking and drug similarity comparisons, spinasterol, diosgenin, and 24-Methylcholest-5-enyl-3belta-O-glucopyranoside_qt may be potential drugs for psoriasis.
format Online
Article
Text
id pubmed-10470816
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104708162023-09-01 A network pharmacology and molecular docking investigation on the mechanisms of Shanyaotianhua decoction (STT) as a therapy for psoriasis Yue, Chen Feng, Jiahao Gao, Aili Medicine (Baltimore) 4000 Psoriasis is an immune-mediated inflammatory skin disease with a complex etiology involving environmental and genetic factors. Psoriasis patients often require long-term treatment. Shanyaotianua decoction (STT), a typical traditional Chinese medicine prescription, positively affects psoriasis, although its molecular targets remain unknown. To elucidate its molecular mechanisms, a combination of network pharmacology, bioinformatics analysis, and drug similarity comparisons were employed. Participants were separated into 3 groups: non-lesional (NL), lesions after medication (LM), and psoriasis lesion groups (LS). Based on the Gene Ontology/kyoto encyclopedia of genes and genomes enrichment analyses, the key targets were mainly enriched for biological processes (immuno-inflammatory responses, leukocyte differentiation, lipid metabolic disorders, and viral infection) with the relevant pathways (Janus kinase/signal transducers and activators of transcription and adipocytokine signaling and T-helper 17 cell differentiation), thus identifying the possible action mechanism of STT against psoriasis. Target prediction for 18 STT compounds that matched the screening criteria was performed. Then, the STT compounds were intersected with the differentially expressed genes of the psoriatic process, and 5 proteins were potential targets for STT. Based on the open-source toolkit RDKit and DrugBank database, and through molecular docking and drug similarity comparisons, spinasterol, diosgenin, and 24-Methylcholest-5-enyl-3belta-O-glucopyranoside_qt may be potential drugs for psoriasis. Lippincott Williams & Wilkins 2023-08-25 /pmc/articles/PMC10470816/ /pubmed/37653756 http://dx.doi.org/10.1097/MD.0000000000034859 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle 4000
Yue, Chen
Feng, Jiahao
Gao, Aili
A network pharmacology and molecular docking investigation on the mechanisms of Shanyaotianhua decoction (STT) as a therapy for psoriasis
title A network pharmacology and molecular docking investigation on the mechanisms of Shanyaotianhua decoction (STT) as a therapy for psoriasis
title_full A network pharmacology and molecular docking investigation on the mechanisms of Shanyaotianhua decoction (STT) as a therapy for psoriasis
title_fullStr A network pharmacology and molecular docking investigation on the mechanisms of Shanyaotianhua decoction (STT) as a therapy for psoriasis
title_full_unstemmed A network pharmacology and molecular docking investigation on the mechanisms of Shanyaotianhua decoction (STT) as a therapy for psoriasis
title_short A network pharmacology and molecular docking investigation on the mechanisms of Shanyaotianhua decoction (STT) as a therapy for psoriasis
title_sort network pharmacology and molecular docking investigation on the mechanisms of shanyaotianhua decoction (stt) as a therapy for psoriasis
topic 4000
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470816/
https://www.ncbi.nlm.nih.gov/pubmed/37653756
http://dx.doi.org/10.1097/MD.0000000000034859
work_keys_str_mv AT yuechen anetworkpharmacologyandmoleculardockinginvestigationonthemechanismsofshanyaotianhuadecoctionsttasatherapyforpsoriasis
AT fengjiahao anetworkpharmacologyandmoleculardockinginvestigationonthemechanismsofshanyaotianhuadecoctionsttasatherapyforpsoriasis
AT gaoaili anetworkpharmacologyandmoleculardockinginvestigationonthemechanismsofshanyaotianhuadecoctionsttasatherapyforpsoriasis
AT yuechen networkpharmacologyandmoleculardockinginvestigationonthemechanismsofshanyaotianhuadecoctionsttasatherapyforpsoriasis
AT fengjiahao networkpharmacologyandmoleculardockinginvestigationonthemechanismsofshanyaotianhuadecoctionsttasatherapyforpsoriasis
AT gaoaili networkpharmacologyandmoleculardockinginvestigationonthemechanismsofshanyaotianhuadecoctionsttasatherapyforpsoriasis